Updated analysis of CART19-BE-01 trial: An academic trial on the use of ARI-0001 cells (A3B1:CD8: 4-1BB:CD3Z CAR19 cells) in patients with CD19+relapsed / refractory malignancies

BONE MARROW TRANSPLANTATION(2019)

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要